Cas 879367-79-0,2',3'-O-isopropylidene-2-nitro-N<sup>6</sup>-(3-iodobenzyl)adenosine-5'-carboxylic acid

879367-79-0

Post Buying Request

Basic information

Product Name: 2',3'-O-isopropylidene-2-nitro-N⁶-(3-iodobenzyl)adenosine-5'-carboxylic acid
Synonyms: 2',3'-O-isopropylidene-2-nitro-N⁶-(3-iodobenzyl)adenosine-5'-carboxylic acid
CAS NO:879367-79-0
Molecular Formula:
Molecular Weight: 582.311
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2',3'-O-isopropylidene-2-nitro-N⁶-(3-iodobenzyl)adenosine-5'-carboxylic acid(CAS DataBase Reference)
NIST Chemistry Reference: 2',3'-O-isopropylidene-2-nitro-N⁶-(3-iodobenzyl)adenosine-5'-carboxylic acid(879367-79-0)
EPA Substance Registry System: 2',3'-O-isopropylidene-2-nitro-N⁶-(3-iodobenzyl)adenosine-5'-carboxylic acid(879367-79-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 879367-79-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

879367-79-0 Suppliers

Recommended suppliers

879367-79-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 879367-79-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,9,3,6 and 7 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 879367-79:
(8*8)+(7*7)+(6*9)+(5*3)+(4*6)+(3*7)+(2*7)+(1*9)=250
250 % 10 = 0
So 879367-79-0 is a valid CAS Registry Number.

879367-79-0Upstream product

879367-79-0Downstream Products

879367-79-0Relevant academic research and scientific papers

Solid phase synthesis and antiprotozoal evaluation of di- and trisubstituted 5′-carboxamidoadenosine analogues

Rodenko, Boris,Detz, Remko J.,Pinas, Victorine A.,Lambertucci, Catia,Brun, Reto,Wanner, Martin J.,Koomen, Gerrit-Jan

, p. 1618 - 1629 (2006)

The rapid increase of resistance to drugs commonly used in the treatment of tropical diseases such as malaria and African sleeping sickness calls for the prompt development of new safe and efficacious drugs. The pathogenic protozoan parasites lack the cap

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 879367-79-0